Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23590,193,1.17 [1.00-1.37],0.0470117905492102
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20297,404,1.15 [1.03-1.28],0.0117650667064893
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23515,72,1.42 [1.11-1.81],0.0049215197279228
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23668,121,1.25 [1.03-1.52],0.0216016375121763
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23647,100,1.35 [1.10-1.67],0.0048596306590202
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22428,490,1.14 [1.03-1.26],0.0089623493772009
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22448,61,1.38 [1.05-1.81],0.0195687891623887
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23310,53,0.72 [0.52-0.98],0.0390424219936471
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23491,1104,1.10 [1.03-1.18],0.0041312668294173
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23569,312,0.70 [0.62-0.80],1.901567943985515e-07
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23509,252,0.66 [0.57-0.76],2.5075463230033224e-08
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23429,1139,1.11 [1.04-1.19],0.0012608865089071
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20306,1097,1.10 [1.03-1.18],0.0040298667699631
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",17166,73,0.75 [0.57-0.98],0.0352690574152208
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17365,272,1.19 [1.04-1.35],0.0113450244833236
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20969,3876,1.07 [1.03-1.11],0.0002690342223147
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17666,573,1.10 [1.00-1.21],0.0406421036020188
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17404,311,1.17 [1.03-1.32],0.0169209606334699
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17829,736,1.09 [1.00-1.18],0.0390407903962715
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17662,569,1.12 [1.02-1.23],0.0142631413691163
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22292,5199,1.05 [1.02-1.08],0.0022340925105587
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22836,22,1.72 [1.12-2.65],0.0137041225573723
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22752,84,1.28 [1.02-1.62],0.035316341675641
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22943,2160,1.05 [1.00-1.10],0.0361556015413549
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22967,354,0.88 [0.78-1.00],0.0483983070915896
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22473,246,1.15 [1.00-1.32],0.0461774946297572
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19966,7737,1.03 [1.00-1.05],0.0337385369440643
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertension,21168,6742,1.04 [1.02-1.07],0.0017958081185447
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21191,6765,1.04 [1.02-1.07],0.0019111286063845
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypotension,23583,1228,1.09 [1.02-1.16],0.0102220623026167
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22799,572,1.12 [1.02-1.23],0.0128857274515321
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20389,960,1.07 [1.00-1.15],0.0483804325561658
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20604,1175,1.08 [1.02-1.16],0.0120766587086841
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23713,61,1.35 [1.03-1.76],0.0270475777758812
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23190,93,1.38 [1.11-1.72],0.0034715347576897
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23640,150,1.20 [1.01-1.43],0.0399774850685306
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23113,28,0.61 [0.39-0.95],0.0291890801702226
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22613,122,1.25 [1.03-1.52],0.021030627553487
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23486,389,1.18 [1.05-1.31],0.0036982717021861
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22793,129,0.82 [0.67-1.00],0.0465241257931036
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16531,1430,1.06 [1.00-1.12],0.0410806210228874
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16848,1404,1.06 [1.00-1.13],0.0411331628955501
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20376,46,1.70 [1.26-2.29],0.00045518860876
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22877,2547,1.06 [1.02-1.11],0.0066229666746263
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21724,5262,1.04 [1.01-1.07],0.0175951944466786
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23488,2148,1.05 [1.01-1.11],0.0301532129471907
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23461,1001,1.11 [1.03-1.19],0.0037292808855882
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23449,2192,1.07 [1.02-1.12],0.0049165693806332
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23636,452,1.11 [1.00-1.23],0.0453053516768259
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23610,1388,1.10 [1.03-1.16],0.0019058166478125
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural effusion,22379,1122,1.07 [1.00-1.14],0.0463442869519338
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23225,1885,1.06 [1.00-1.11],0.0361588051929028
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23444,984,1.11 [1.03-1.19],0.0036839323472751
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23639,472,1.12 [1.02-1.24],0.0222911015077811
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23641,292,1.14 [1.00-1.29],0.0462456944100197
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21911,268,0.87 [0.76-1.00],0.043934241491637
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21650,4765,1.04 [1.01-1.07],0.0128996441671052
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20187,6250,1.04 [1.01-1.07],0.0050887769624752
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22675,93,0.78 [0.61-0.98],0.0345680237150741
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20558,166,0.83 [0.70-0.99],0.0400553189871606
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20444,52,1.41 [1.06-1.87],0.0188113111491262
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17860,975,1.11 [1.03-1.19],0.0038111626443857
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23589,961,1.11 [1.03-1.19],0.0046791635711239
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23439,56,1.42 [1.07-1.87],0.0150980299795334
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21376,984,1.07 [1.00-1.15],0.0432728876464801
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19148,2263,1.07 [1.02-1.12],0.0047821804394915
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20894,214,1.19 [1.03-1.38],0.0182176821288053
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23423,40,1.50 [1.09-2.08],0.0133329462756697
